Global Diabetic Neuropathy Market 2014-2018

2014-05-09
Price :
Published : May-2014
No. of Pages : 55

Report Description

Diabetes is usually associated with progressive damage to the nervous system, which leads to disorders collectively known as diabetic neuropathy. Diabetic neuropathy is characterized by progressive damage to the neuronal myelin sheath, which slows down nerve conduction velocity. Axonal damage associated with diabetic neuropathy decreases nerve action potential below normal physiological level, which inhibits neuronal signal transmission. About 60 to 70 percent of the diabetic population develops neuropathy, with a considerable number of cases going undiagnosed during the initial years of progression. Disease management should start with the initial diagnosis of diabetes, from educating patients to giving them regular check-ups. Diabetic neuropathy treatment involves bringing blood glucose levels within the normal range to check for further nerve damage and also additional treatment to provide symptomatic relief. Alternative therapies, which help in managing pain, such as biofeedback, meditation, acupuncture or other relaxation techniques can also be used.

TechNavio’s analysts forecast the Global Diabetic Neuropathy market will grow at a CAGR of 8.41 percent over the period 2014-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Diabetic Neuropathy market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various pain management drugs administered to relieve the pain symptoms associated with diabetic neuropathy. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Diabetic Neuropathy market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio’s report, the Global Diabetic Neuropathy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Diabetic Neuropathy market landscape and its growth prospects in the coming years.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Eli Lilly and Co.
  • Janssen Pharmaceuticals Inc.
  • Pfizer Inc.

Other Prominent Vendors

  • Actavis plc
  • Cephalon Inc.
  • MEDA Pharma GmbH & Co. KG

Key Market Driver

  • Increasing Global Diabetic Population.
  • For a full, detailed list, view our report.

Key Market Challenge

  • High Failure Rate in Clinical Trials.
  • For a full, detailed list, view our report.

Key Market Trend

  • Increasing R&D Activities.
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05. Introduction

06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07. Geographical Segmentation

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Market Share Analysis 2013
15.3 Other Prominent Vendors

16. Key Vendor Analysis
16.1 Pfizer Inc.
16.1.1 Business Overview
16.1.2 Key Information
16.1.3 SWOT Analysis
16.2 Eli Lilly and Company
16.2.1 Business Overview
16.2.2 Business Segmentation
16.2.3 Key Information
16.2.4 SWOT Analysis
16.3 Janssen Pharmaceuticals Inc.
16.3.1 Business Overview
16.3.2 Key Information
16.3.3 SWOT Analysis

17. Pipeline Analysis
17.1 Phase III Analysis
17.2 Phase II Analysis
17.3 Phase I Analysis
17.4 Discontinued Projects
17.5 Projects on Hold
17.6 Promising Pipeline Molecules
17.6.1 Phase III Promising Pipeline Molecules
17.6.2 Phase II Promising Pipeline Molecules
17.7 Other First-in-class Pipeline Molecules:

18. Other Reports in this Series

List of Exhibits:

Exhibit 1: Market Research Methodology
Exhibit 2: Global Diabetic Neuropathy Market 2013-2018 (US$ billion)
Exhibit 3: Global Diabetic Neuropathy Market by Geographical Segmentation 2013
Exhibit 4: Eli Lilly and Company: Business Segmentation
Exhibit 5: Diabetic Neuropathy Pipeline Snapshot 2013
Exhibit 6: Discontinued Pipeline Molecules on the basis of MOA

Filed in: Pharmaceutical, Therapeutics
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Global Bio-Surfactants Market 2015-2019

Bio-surfactants are an assorted gathering of active molecules that can be produced by integrating living cells or micro-organisms, such as bacteria, fungi, and yeast. Bio-based surfactants can be produced from oleochemical raw materials such as vegetable oils, animal fats, sucrose, and glucose. Due to their excellent foaming, wetting, emulsifying, and detergency traits, bio-surfactants have emerged as the most versatile bio-process chemicals and are widely in various industries such as cosmetics, personal care, bioremediation, pharmaceuticals, agriculture, and food processing. The analysts forecast global bio-surfactants market to grow at a CAGR of 6.14% over the period 2015-2019. Covered in this Report This report covers the present scenario and the growth prospects of the global......
$3000

EMR/EHR Market in the US 2015-2019

An EMR/EHR is defined is a digital version of the traditional paper-based medical record for a patient, which includes the patient's information, history of care, clinical data, and information from multiple sources that are maintained within a hospital, clinic, or health center. Recently, the terms EMR and EHR have been used interchangeably. An EMR/EHR permits a clinician to track data over time, identify patients due for preventative screenings, help check patients on certain parameters such as blood pressure readings or vaccines, and monitor overall quality of care within the practice. An EMR/EHR helps make the process of patient record keeping easier, more accurate, comprehensive, and more efficient. EMR/EHR is one of the best ways to boost patient safety, manage chronic illnesses, and......
$2500

Global Diabetic Retinopathy Market 2015-2019

Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease. Laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy are some of the available treatments. One feature of diabetic retinopathy is diabetic macular edema. This is a serious medical condition involvi......
$2500

Global Hemodialysis Market 2015-2019

Hemodialysis is a procedure in which excess fluids and toxins are mechanically filtered from the blood of individuals when the kidneys are not able to function normally. It is the treatment used when there is an acute and chronic disturbance in the functioning of the kidneys. It plays a major role in improving a patient's quality of life. For hemodialysis, vascular access is needed for blood to flow out of the body to be filtered and pumped by a hemodialysis machine through a dialyzer. Hemodialysis can be performed in an in-center facility or at home. The analysts forecast global hemodialysis market to grow at a CAGR of 4.73% over the period 2015-2019. Covered in this Report The global hemodialysis market is divided into two segments: hemodialysis products and services. The rep......
$2500

Healthcare IT Market in Saudi Arabia 2015-2019

Over the years, businesses in Saudi Arabia have been adopting advanced technologies and IT integration solutions to enhance their operations and revenue. With more and more operations being enabled and enriched by innovative IT applications and solutions, IT has become a key enabler of business functions. This trend is also being witnessed in the healthcare sector in Saudi Arabia. The need to maintain a standard record format has led to the transformation of traditional medical records to electronic health records. Implementation of the policy that makes insurance mandatory is also contributing to the growth of this market. The need to track common ailments has also intensified the need for IT. In addition, the inherent benefits of IT, such as process efficiency, cost-effectiveness, mobili......
$2500

Global Peritoneal Dialysis Market 2015-2019

Peritoneal dialysis is a needle-free treatment and can be performed either by a patient or with the help of a care partner. It is used to remove waste products and extra fluid from the body during the issue with kidney functions. Peritoneal dialysis differs from hemodialysis as in this treatment the blood is not taken from the body to treat the patient. In peritoneal dialysis, a tube called PD catheter is placed in the belly of the patient, and the dialysis is carried out by sterile fluid flowing through the lining of the belly called the peritoneum. This helps the blood flow into and out of the peritoneal space and the blood is cleansed inside the body. The analysts forecast global peritoneal dialysis market to grow at a CAGR of 4.40% over the period 2014-2019. Covered in this repor......
$2500

Global Neurodegenerative Diseases Market 2015-2019

According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain. These conditions can affect balance, movement, speech, and respiratory and cardiac functions. They can be inherited or be of unknown etiology. Neurodegenerative diseases are incurable and are severely debilitating. They result in progressive degeneration of nerve cells, causing them to die eventually. These diseases cause ataxia and dementia in people, which can have a serious impact on the mental health of patients. Some examples of neurodegenerative diseases are Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, and epilepsy. Huntington's disease and amyotrophic lateral sclerosis are rare diseases, unlike Alzheimer......
$3500

Global Osteoporosis Drugs Market 2015-2019

Osteoporosis, or porous bone, is a disease characterized by low bone density and structural deterioration of bone tissue, leading to fragile bones. As bones becomes fragile, risk of fracture increases. Osteoporosis primarily affects women, but can also affect men. In women, bone loss occurs rapidly in the first few years after menopause and continues through the postmenopausal stage. Osteoporosis progresses when bone resorption occurs too quickly or when replacement is too slow. Risk factors for osteoporosis include gender, age, low body weight, ethnicity, and family history. Some of the risk factors that can be manipulated include sex hormones, medication use, intake of calcium and vitamins, alcohol intake, and smoking. The analysts forecast global osteoporosis drugs market to grow at ......
$2500

Pharmaceutical Packaging Market in Europe 2015-2019

Pharmaceutical packaging products are used to protect pharmaceuticals from contamination by external toxins and microbial activity, and to extend their shelf life. Also, drug manufacturers need to comply with international packaging regulations. Various raw materials such as plastic resins, glass, paper and paperboard, aluminum, and other metals are used in the production of pharmaceutical packaging. They are available as bottles, parenteral containers, blister packs, caps, closures, pre-fillable syringes, and tubes. The key end-customers of these packaging products are manufacturers of pharmaceuticals. The analysts forecast pharmaceutical packaging market in Europe to grow at a CAGR of 7.26 percent over the period 2014-2019. Covered in this report The pharmaceutical packaging mar......
$2500

Telemedicine Market in BRIC 2015-2019

Telemedicine is defined as the application of telecommunication technology to provide clinical healthcare to patients, particularly in remote patient care. There are various technologies and devices such as cameras, internet, satellites, and wireless communication that are used to provide telemedicine services, for instance, videoconferencing. Telemedicine provides clinical care services mainly through two technologies: pre-captured and real-time. Telemedicine helps eliminate distance barriers and improves access to medical services that would often not be easily accessible in rural areas. Moreover, it helps save lives in critical care and emergency situations. The analysts forecast telemedicine market in BRIC to grow at a CAGR of 16.14% over the period 2014-2019. Covered in this rep......
$2500